PUBLISHER: The Business Research Company | PRODUCT CODE: 1942797
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942797
Electrophysiology catheters are specialized medical devices used in electrophysiology to diagnose and treat heart rhythm disorders. These catheters are inserted into the heart via blood vessels to record electrical activity, map electrical pathways, and provide therapeutic treatments. They are primarily utilized in procedures conducted in specialized settings such as electrophysiology labs within hospitals or clinics.
The main types of electrophysiology catheters include diagnostic catheters, ablation catheters, and others. Electrophysiology diagnostic catheters are specifically designed to identify heart rhythm disorders. They are distributed through both online and offline channels and used for diagnosis and monitoring, treatment of cardiac arrhythmias, imaging, mapping, and other applications. End users of these devices include hospitals, ambulatory surgical centers, cardiac catheterization labs, and other healthcare facilities.
Tariffs are impacting the electrophysiology catheters market by increasing the cost of imported catheter components, specialty polymers, sensors, and precision-manufactured materials. These effects are most visible across diagnostic and ablation catheter segments, particularly in regions reliant on international medical device supply chains such as Asia-Pacific and Europe. Elevated tariffs have modestly increased procurement costs for hospitals and cardiac catheterization labs. At the same time, tariffs are encouraging localized manufacturing, supplier diversification, and regional production capabilities, strengthening long-term supply resilience.
The electrophysiology catheters market research report is one of a series of new reports from The Business Research Company that provides electrophysiology catheters market statistics, including electrophysiology catheters industry global market size, regional shares, competitors with a electrophysiology catheters market share, detailed electrophysiology catheters market segments, market trends and opportunities, and any further data you may need to thrive in the electrophysiology catheters industry. This electrophysiology catheters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The electrophysiology catheters market size has grown rapidly in recent years. It will grow from $7.58 billion in 2025 to $8.55 billion in 2026 at a compound annual growth rate (CAGR) of 12.8%. The growth in the historic period can be attributed to increasing prevalence of cardiac arrhythmias, growth in hospital-based electrophysiology labs, rising adoption of catheter ablation procedures, expanding cardiology infrastructure, improved physician expertise in electrophysiology.
The electrophysiology catheters market size is expected to see rapid growth in the next few years. It will grow to $13.83 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to aging population with heart rhythm disorders, increasing demand for minimally invasive cardiac treatments, expansion of ambulatory cardiac centers, rising awareness of arrhythmia management, growing healthcare spending on cardiac care. Major trends in the forecast period include rising adoption of catheter-based arrhythmia treatments, growing demand for advanced cardiac mapping catheters, increasing use of minimally invasive electrophysiology procedures, shift toward high-precision ablation catheters, rising procedure volumes in dedicated electrophysiology labs.
The growing prevalence of cardiovascular diseases is expected to drive the expansion of the electrophysiology catheter market. Cardiovascular diseases, which affect the heart and blood vessels, can lead to complications such as heart attacks, strokes, and heart failure. The rising rates of cardiovascular diseases are attributed to factors such as unhealthy diets, sedentary lifestyles, smoking, and excessive alcohol consumption. Electrophysiology catheters are essential for diagnosing and treating heart rhythm disorders, as they map electrical activity and deliver targeted therapeutic interventions. For example, in October 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, cardiovascular disease claimed 919,032 lives in 2023, representing approximately one in every three deaths. This increase is slightly lower than the 4.6% rise seen the year before. As a result, the growing prevalence of cardiovascular diseases is propelling the growth of the electrophysiology catheter market.
Major companies operating in the electrophysiology catheters market are focusing on developing innovative solutions such as pulsed field ablation to enhance the safety, precision, and efficiency of cardiac arrhythmia treatments. Pulsed field ablation (PFA) is a non-thermal cardiac ablation technique that uses high-voltage, short-duration electrical pulses to selectively destroy abnormal heart tissue while minimizing damage to surrounding structures. For example, in October 2024, Medtronic Plc., an Ireland-based medical technology company, received FDA approval for the Affera Mapping and Ablation System and the Sphere-9 Catheter. This innovative, all-in-one electrophysiology tool combines high-density cardiac mapping and dual-energy ablation (pulsed field and radiofrequency) in a single catheter. The system simplifies complex arrhythmia procedures by enabling mapping and ablation with high precision using a single catheter, improving workflow efficiency and reducing procedure times. Its purpose is to provide safer, more effective treatment for persistent atrial fibrillation and atrial flutter, with demonstrated clinical safety and efficacy benefits for both patients and physicians.
In January 2024, CardioFocus, a US-based medical device company, acquired the Electrophysiology Technology division of Galvanize Therapeutics for an undisclosed sum. This acquisition brings together the CENTAURI System, a pulsed electric field generator CE-marked and available in the EU and UK, and the QuickShot catheter ablation system, which is still under development. It also includes a broad intellectual property portfolio, featuring licenses to several key patent families for pulsed electric field therapies. Galvanize Therapeutics is a US-based manufacturer specializing in electrophysiology catheters.
Major companies operating in the electrophysiology catheters market are Johnson & Johnson Services Inc., Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Biotronik SE & Co KG, MicroPort Scientific Corporation, AtriCure Inc., Stereotaxis Inc., Acutus Medical Inc., Imricor Medical Systems Inc., OSYPKA AG, CardioFocus Inc., Terumo Corporation, Asahi Intecc Co Ltd, Cook Medical, Japan Lifeline Co Ltd, Lepu Medical Technology Co Ltd, Kardium Inc., CathVision ApS, APN Health LLC
North America was the largest region in the electrophysiology catheters market in 2025. The regions covered in the electrophysiology catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the electrophysiology catheters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The electrophysiology catheters market consists of sales of mapping catheters, biosensing catheters, electrode catheters and cryoablation catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Electrophysiology Catheters Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses electrophysiology catheters market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for electrophysiology catheters ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electrophysiology catheters market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.